April 29, 2025

Progression in Parkinson’s

α-Synuclein PET tracer shows potential to diagnose and monitor the disease

The Pathologist

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant

April 29, 2025

RadSearch Transforms Radiology Report Retrieval 

RadSearch could enhance radiologists' ability to find precedent cases.

Conexiant

April 28, 2025

DaT Imaging Tracks Parkinson’s Motor Symptom Progression

A large Parkinson’s study found that a decline in dopamine transporter signals in the less affected putamen tracks worsening motor symptoms, supporting the use of DaT imaging for monitoring disease progression.

Conexiant

April 23, 2025

Sense of Belonging 'Critical' for Workplace Retention

Individuals who reported a neutral level of satisfaction with their sense of belonging were approximately 3 times more likely to express an intent to leave, while those who were dissatisfied were 7 times more likely to do so, compared to individuals who were satisfied with their sense of belonging.

Conexiant

April 21, 2025

Transfusion Strategy Outcomes After Aneurysmal SAH Similar, Study Reveals

SAHaRA trial investigators compared a liberal (transfusion at hemoglobin levels of 10 g/dL or lower) and a restrictive (transfusion at 8 g/dL or lower) red-cell tranfusion strategy among critically ill patients with acute aneurysmal subarachnoid hemorrhage (SAH) and anemia.

Conexiant

April 17, 2025

Climate Identified as Key Virus Driver

Researchers found Oropouche virus to be underreported during a large-scale study across Latin America, with climate emerging as the primary driver of transmission risk.

Conexiant

April 10, 2025

Caution Urged Over Biomarker Screening for Alzheimer’s

Blood tests could rule out dementia risk, but can’t reliably predict it, study finds

The Pathologist

April 07, 2025

GLP-1, SGLT2 Found to Reduce Alzheimer's Risk

New study finds GLP-1 agonists and SGLT2 inhibitors associated with reduced risk of dementia in type 2 diabetes patients compared to other glucose-lowering medications.

Conexiant